Company Registration No. 11299513 (England and Wales)
GV Pharma Ltd
Unaudited accounts
for the year ended 30 April 2021
GV Pharma Ltd
Unaudited accounts
Contents
GV Pharma Ltd
Company Information
for the year ended 30 April 2021
Company Number
11299513 (England and Wales)
Registered Office
STUDIO 5 RIVERSIDE STUDIOS
MILL LANE
DRONFIELD
DERBYSHIRE
S18 2XL
GV Pharma Ltd
Statement of financial position
as at 30 April 2021
Cash at bank and in hand
2,008
34,296
Creditors: amounts falling due within one year
(11,870)
(62,832)
Net current liabilities
(8,238)
(12,124)
Net liabilities
(8,238)
(12,124)
Profit and loss account
(8,338)
(12,224)
Shareholders' funds
(8,238)
(12,124)
For the year ending 30 April 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 31 December 2021 and were signed on its behalf by
Gerald Banda
Director
Company Registration No. 11299513
GV Pharma Ltd
Notes to the Accounts
for the year ended 30 April 2021
GV Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 11299513. The registered office is STUDIO 5 RIVERSIDE STUDIOS, MILL LANE, DRONFIELD, DERBYSHIRE, S18 2XL.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
These financial statements for the year ended 30 April 2021 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 1 May 2019.
The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously.
The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
4
Average number of employees
During the year the average number of employees was 1 (2020: 1).
